Orvida Pharma (formerly Kamari Pharma)
4 clinical trials · Sponsor
◉ Watch Orvida Pharma (formerly Kamari Pharma)
| Record | Firm | Date |
|---|---|---|
| Study of KM-023 in Healthy Volunteers and Patients With Olmsted Syndrome. (NCT07090889) | Orvida Pharma (formerly Kamari Pharma) | 2025-07-08 |
| Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC (NCT05956314) | Orvida Pharma (formerly Kamari Pharma) | 2023-03-06 |
| Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases (NCT05435638) | Orvida Pharma (formerly Kamari Pharma) | 2022-07-17 |
| KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC) (NCT05454462) | Orvida Pharma (formerly Kamari Pharma) | 2022-05-24 |
Track Orvida Pharma (formerly Kamari Pharma) automatically
Every clearance here is in the API, with alerts when new ones post.